✦ LIBER ✦

The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic, inflammatory and neoplastic disorders

✍ Scribed by Stepanov, Vanesa; Stankov, Karmen; Mikov, Momir

Book ID: 120518218
Publisher: Informa plc
Year: 2013
Tongue: English
Weight: 313 KB
Volume: 33
Category: Article
ISSN: 1079-9893
DOI: 10.3109/10799893.2013.802805

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The bile acid membrane receptor TGR5: a

The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic syndrome

✍ Vanesa Stepanov, Karmen Stankov, Momir Mikov 📂 Article 📅 2012 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 75 KB

Bile Acid Mimetic-Activated TGR5 Recepto

Bile Acid Mimetic-Activated TGR5 Receptor in Metabolic-Related Liver Disorder: The Good and the Bad

✍ Raoul Poupon 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 157 KB

The Bile Acids Receptor TGR5 is an Essen

The Bile Acids Receptor TGR5 is an Essential Modulator of Intestinal Membrane Permeability and Exerts Anti-Inflammatory Activities in Rodent Model of Colitis

✍ Sabrina Cipriani; Barbara Renga; Andrea Mencarelli; Eleonora Distrutti; Stefano 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 161 KB

The nuclear bile acid receptor FXR as a

The nuclear bile acid receptor FXR as a novel therapeutic target in cholestatic liver diseases: Hype or hope?

✍ Michael Trauner 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB 👁 2 views

Farnesoid X receptor (FXR) is a bile acid-activated transcription factor that is a member of the nuclear hormone receptor superfamily. FXR-null mice exhibit a phenotype similar to Byler disease, an inherited cholestatic liver disorder. In the liver, activation of FXR induces transcription of transpo